The effects of acteoside on locomotor recovery after spinal cord injury - The role of autophagy and apoptosis signaling pathway

Biomed Pharmacother. 2024 Jun:175:116607. doi: 10.1016/j.biopha.2024.116607. Epub 2024 Apr 30.

Abstract

In the current study, we investigated the effects of acteoside as a phenylpropanoid glycoside on interaction with neurons to assesses locomotor recovery after spinal cord injury (SCI) in rats by focusing on evaluating the factors involved in autophagy, apoptosis, inflammation and oxidative stress processes. 49 Spargue-Dawley rats were prepared and divided into seven healthy and SCI groups receiving different concentrations of acteoside. After 28 days of disease induction and treatment with acteoside, a BBB score test was used to evaluate locomotor activity. Then, by preparing spinal cord cell homogenates, the expression levels of MAP1LC3A, MAP-2, glial fibrillary acidic protein (GFAP), Nrf2, Keap-1, Caspase 3 (Casp3), Bax, Bcl-2, TNF-a, IL-1B, reactive oxygen species (ROS), and malondialdehyde (MDA) were measured. Improvement of locomotor activity in SCI rats receiving acteoside was observed two weeks after the beginning of the experiment and continued until the fourth week. Both MAP1LC3A and MAP-2 were significantly up-regulated in SCI rats treated with acteoside compared to untreated SCI rats, and GFAP levels were significantly decreased in these animals. Pro-apoptotic proteins Bax and Casp3 and anti-apoptotic protein Bcl-2 were down-regulated and up-regulated, respectively, in SCI rats receiving acteoside. In addition, a significant downregulation of iNOS, TNF-α, and IL-1β and a decrease in contents of both ROS and MDA as well as increases in Nrf2 and Keap-1 were seen in rats receiving acteoside. Furthermore, acteoside strongly interacted with MAP1LC3A, TNF-α, and Casp3 targets with binding affinities of -8.3 kcal/mol, -8.3 kcal/mol, and -8.5 kcal/mol, respectively, determined by molecular docking studies. In general, it can be concluded that acteoside has protective effects in SCI and can be considered as an adjuvant therapy in the treatment of this disease. However, more studies, especially clinical studies, are needed in this field.

Keywords: Acteoside; Apoptosis; Autophagy; Cytokine; Spinal cord injury.

MeSH terms

  • Animals
  • Apoptosis* / drug effects
  • Autophagy* / drug effects
  • Disease Models, Animal
  • Glucosides* / pharmacology
  • Locomotion / drug effects
  • Male
  • Neuroprotective Agents / pharmacology
  • Oxidative Stress / drug effects
  • Phenols* / pharmacology
  • Polyphenols
  • Rats
  • Rats, Sprague-Dawley*
  • Recovery of Function* / drug effects
  • Signal Transduction* / drug effects
  • Spinal Cord / drug effects
  • Spinal Cord / metabolism
  • Spinal Cord Injuries* / drug therapy
  • Spinal Cord Injuries* / metabolism
  • Spinal Cord Injuries* / physiopathology

Substances

  • acteoside
  • Glucosides
  • Phenols
  • Neuroprotective Agents
  • Polyphenols